Clinical Trial Results:
            A Phase 1b, Randomized, Subject- and Investigator-Blinded, Placebo-Controlled, Multi-Center Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Biomarkers of Inhaled GB002 in Subjects with WHO Group 1 Pulmonary Arterial Hypertension (PAH)
    
|     Summary | |
|     EudraCT number | 2018-003093-27 | 
|     Trial protocol | GB | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v1 | 
|     This version publication date | 
                                    16 Jul 2022
                             | 
|     First version publication date | 
                                    16 Jul 2022
                             | 
|     Other versions | v2 | 
|     Summary report(s) | GB002-1101 - no subjects enrolled in EU/EEA/UK | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
